CLINICAL_TRIALS
trial_result
· 2023-10-19
Clinical Trial Update: Pembrolizumab Activity in Patients With Homologous Recombination Competent and Deficient Tumors [Phase 2]
Summary
Phase 2 trial update on pembrolizumab activity in tumors with homologous recombination competency status, completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Baptist Health South Florida | Conditions: Solid Tumor, Adult | Phase 2 | Status: COMPLETED | Results posted: 2023-10-19